ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,416.45
0.00%
Dow Jones
39,872.99
0.17%
Gold vs US Dollar
2,416.52
-0.20%
Brent Oil
81.745
-0.85%
Bitcoin
69,812.39
-0.45%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. BriaCell Therapeutics Corporation (BCTX)

  7. BriaCell Therapeutics Corporation (BCTX) News

BriaCell Therapeutics (BCTX)

BriaCell Therapeutics Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BCTX
DateTimeSourceHeadlineSymbolCompany
17/05/202421:33GlobeNewswire Inc.BriaCell Therapeutics Announces Closing of $5.0 Million Registered Direct OfferingNASDAQ:BCTXBriaCell Therapeutics Corporation
15/05/202413:00GlobeNewswire Inc.BriaCell Therapeutics Announces Pricing of $5.0 Million Registered Direct OfferingNASDAQ:BCTXBriaCell Therapeutics Corporation
24/04/202413:00GlobeNewswire Inc.BriaCell Announces Oral and Poster Presentations at ASCO 2024NASDAQ:BCTXBriaCell Therapeutics Corporation
10/04/202413:00GlobeNewswire Inc.BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+™ and Bria-PROS+™ Clinical Candidates for Breast and Prostate CancerNASDAQ:BCTXBriaCell Therapeutics Corporation
09/04/202413:00GlobeNewswire Inc.BriaCell Showcases Data Demonstrating Unmatched Progression-Free Survival (PFS) and Clinical Efficacy in Antibody-Drug Conjugate (ADC) Resistant and Central Nervous System (CNS) Metastatic Breast Cancer at the 2024 AACRNASDAQ:BCTXBriaCell Therapeutics Corporation
07/03/202413:00GlobeNewswire Inc.BriaCell Receives and Executes Letter of Intent to Advance Clinical Development of Breast and Prostate Cancer ImmunotherapiesNASDAQ:BCTXBriaCell Therapeutics Corporation
06/03/202413:00GlobeNewswire Inc.BriaCell to Present Clinical Data in Central Nervous System (CNS) Metastasis and Antibody-Drug Conjugate (ADC) Resistant Breast Cancer at the 2024 AACR ConferenceNASDAQ:BCTXBriaCell Therapeutics Corporation
27/02/202413:00GlobeNewswire Inc.BriaCell Provides Update on Alleged Illegal Trading of Public SecuritiesNASDAQ:BCTXBriaCell Therapeutics Corporation
07/02/202413:00GlobeNewswire Inc.BriaCell Announces Strong Clinical Data in Breast Cancer Patients; Reports Another Notable Responder CaseNASDAQ:BCTXBriaCell Therapeutics Corporation
06/02/202413:30GlobeNewswire Inc.Breaking Ground in Prostate Cancer: BriaCell Announces Lead Prostate Cancer Candidate Bria-Pros+, Initiates GMP ManufacturingNASDAQ:BCTXBriaCell Therapeutics Corporation
01/02/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BCTXBriaCell Therapeutics Corporation
31/01/202422:24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCTXBriaCell Therapeutics Corporation
31/01/202403:48GlobeNewswire Inc.BriaCell Therapeutics Corp. Announces Results of Shareholder MeetingNASDAQ:BCTXBriaCell Therapeutics Corporation
22/01/202422:00Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BCTXBriaCell Therapeutics Corporation
09/01/202421:05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BCTXBriaCell Therapeutics Corporation
08/01/202416:01Edgar (US Regulatory)Form SCHEDULE 13G -NASDAQ:BCTXBriaCell Therapeutics Corporation
04/01/202413:45GlobeNewswire Inc.BriaCell Images Confirm Robust Anti-Tumor Activity in Patient with “Eye-Bulging” Metastatic Breast CancerNASDAQ:BCTXBriaCell Therapeutics Corporation
28/12/202313:55GlobeNewswire Inc.BriaCell Reports 71% Central Nervous System Response Rate in Advanced Breast Cancer PatientsNASDAQ:BCTXBriaCell Therapeutics Corporation
20/12/202321:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCTXBriaCell Therapeutics Corporation
20/12/202313:40GlobeNewswire Inc.BriaCell Reports Unprecedented Preliminary Survival and Clinical Benefit in Antibody-Drug Conjugate (ADC) Refractory Patient SubsetNASDAQ:BCTXBriaCell Therapeutics Corporation
14/12/202322:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BCTXBriaCell Therapeutics Corporation
14/12/202322:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCTXBriaCell Therapeutics Corporation
06/12/202314:31GlobeNewswire Inc.BriaCell Highlights Outstanding Topline Survival and Clinical Benefit Data in Advanced Metastatic Breast Cancer at the 2023 SABCSNASDAQ:BCTXBriaCell Therapeutics Corporation
06/12/202314:00GlobeNewswire Inc.BriaCell 2023 SABCS Posters Confirm Activation of Cancer-Fighting Immune Cells and Identify Potential Predictors of Clinical BenefitNASDAQ:BCTXBriaCell Therapeutics Corporation
30/11/202312:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCTXBriaCell Therapeutics Corporation
30/11/202312:00GlobeNewswire Inc.BriaCell Records New Responder with Remarkable Improvement of “Eye-Bulging” Metastatic TumorNASDAQ:BCTXBriaCell Therapeutics Corporation
03/11/202312:31GlobeNewswire Inc.BriaCell Reports Unprecedented Anti-Tumor Activity of its Next Generation Personalized Breast and Prostate Cancer Immunotherapies in Tumor Models at the 2023 SITC Annual Meeting; FDA Greenlights Bria-OTS™ INDNASDAQ:BCTXBriaCell Therapeutics Corporation
25/10/202314:15GlobeNewswire Inc.BriaCell Forms Medical Advisory Board of Distinguished Breast Cancer Specialists to Advance its Lead Oncology CandidateNASDAQ:BCTXBriaCell Therapeutics Corporation
20/10/202314:15GlobeNewswire Inc.October is Breast Cancer Awareness Month – BriaCell is Leading the Fight with its Innovative TechnologyNASDAQ:BCTXBriaCell Therapeutics Corporation
18/10/202314:00GlobeNewswire Inc.BriaCell Announces Presentations at the 2023 Society for the Immunotherapy of Cancer (SITC) and San Antonio Breast Cancer (SABC) ConferencesNASDAQ:BCTXBriaCell Therapeutics Corporation
 Showing the most relevant articles for your search:NASDAQ:BCTX

Your Recent History

LSE
POLX
Polarean Imaging
LSE
GKP
Gulf Keystone Petroleum
LSE
ZED
Zenova
LSE
PHNX
Phoenix
LSE
LLOY
Lloyds Banking
LSE
RGL
Regional Reit
LSE
OBI
Ondine Biomedical
LSE
RKH
Rockhopper Exploration
LSE
PHE
Powerhouse Energy
LSE
W7L
Warpaint London
LSE
LGEN
Legal & General
LSE
CYAN
Cyanconnode
LSE
NFDS
Northern Foods
LSE
BOO
Boohoo
LSE
TERN
Tern
LSE
VEL
Velocity Composites
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved